Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05584501 · ClinicalTrials.gov registry record · NA
ETE Interventions in the Dental Setting
A NA study of HIV Infections, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 153
- Enrollment target
- 2
- Study locations
NCT05584501: Recruiting NA study of HIV Infections, sponsored by Columbia University.
NCT05584501 is a NA study of HIV Infections that is actively recruiting participants, run by Columbia University. The registered enrollment target is 153 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05584501, a NA study of HIV Infections, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to use information technology (IT) to support the delivery of HIV prevention and care best practices in the dental care setting to meet the Department of Health and Human Services (DHHS) Ending the HIV Epidemic (ETE) goals.
Conditions Studied
Interventions
- OTHER Care Navigator
- OTHER Health Information Supported Ending the HIV Epidemic (ETE) Activities in Dental Setting
Study Locations (2)
New York
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital - New York
- Weill Cornell Medical Center / NewYork-Presbyterian Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2024-10 |
| Phase | NA |
What NCT05584501 shows while recruiting
NCT05584501 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (66% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Care Navigator is the first listed.
NCT05584501 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05584501 about?
NCT05584501 is a clinical study titled "ETE Interventions in the Dental Setting". The purpose of this study is to use information technology (IT) to support the delivery of HIV prevention and care best practices in the dental care setting to meet the Department of Health and Human Services (DHHS) Ending the HIV Epidemic (ETE) goals.
What is the current status of trial NCT05584501?
This trial is currently recruiting. It is a NA study. The enrollment target is 153 participants. The study started on 2022-09-26. Estimated completion is 2024-10.
What conditions does trial NCT05584501 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT05584501?
The interventions under investigation include: Care Navigator (OTHER), Health Information Supported Ending the HIV Epidemic (ETE) Activities in Dental Setting (OTHER).
Who is sponsoring clinical trial NCT05584501?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05584501 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05584501's enrollment target sits among peer trials
153 210th of 542 higher than 333 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- NCT06293352 · 153 participants · NA
Real-component Vs All-cement Articulating Spacers for Periprosthetic Knee Infection
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI